CRNX
Price
$31.77
Change
-$0.40 (-1.24%)
Updated
Jun 13 closing price
Capitalization
2.98B
54 days until earnings call
IGMS
Price
$1.21
Change
-$0.00 (-0.00%)
Updated
Jun 13 closing price
Capitalization
72.74M
58 days until earnings call
Interact to see
Advertisement

CRNX vs IGMS

Header iconCRNX vs IGMS Comparison
Open Charts CRNX vs IGMSBanner chart's image
Crinetics Pharmaceuticals
Price$31.77
Change-$0.40 (-1.24%)
Volume$557.24K
Capitalization2.98B
IGM Biosciences
Price$1.21
Change-$0.00 (-0.00%)
Volume$148.38K
Capitalization72.74M
CRNX vs IGMS Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. IGMS commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and IGMS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (CRNX: $31.77 vs. IGMS: $1.21)
Brand notoriety: CRNX and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 66% vs. IGMS: 81%
Market capitalization -- CRNX: $2.98B vs. IGMS: $72.74M
CRNX [@Biotechnology] is valued at $2.98B. IGMS’s [@Biotechnology] market capitalization is $72.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 5 TA indicator(s) are bullish while IGMS’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 5 bullish, 3 bearish.
  • IGMS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than IGMS.

Price Growth

CRNX (@Biotechnology) experienced а -3.76% price change this week, while IGMS (@Biotechnology) price change was -8.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

IGMS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.98B) has a higher market cap than IGMS($72.7M). CRNX YTD gains are higher at: -37.864 vs. IGMS (-80.196). IGMS has higher annual earnings (EBITDA): -199.47M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. IGMS (184M). IGMS has less debt than CRNX: IGMS (45.2M) vs CRNX (50.8M). IGMS has higher revenues than CRNX: IGMS (2.68M) vs CRNX (760K).
CRNXIGMSCRNX / IGMS
Capitalization2.98B72.7M4,094%
EBITDA-373.49M-199.47M187%
Gain YTD-37.864-80.19647%
P/E RatioN/AN/A-
Revenue760K2.68M28%
Total Cash1.27B184M692%
Total Debt50.8M45.2M112%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXIGMS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERCX57.17-0.78
-1.35%
American Funds EUPAC R3
MMIUX11.90-0.17
-1.41%
MassMutual Select TRP Intl Equity I
APHJX19.38-0.28
-1.42%
Artisan International Small-Mid Instl
HMVCX10.26-0.15
-1.44%
Hartford MidCap Value C
TPYYX9.11-0.17
-1.83%
Touchstone Sands Capital Intl Gr Eq Y

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.24%
XNCR - CRNX
59%
Loosely correlated
-2.55%
DYN - CRNX
57%
Loosely correlated
-0.35%
TRDA - CRNX
57%
Loosely correlated
-3.31%
IDYA - CRNX
57%
Loosely correlated
-0.45%
RVMD - CRNX
55%
Loosely correlated
-1.26%
More

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
N/A
MRSN - IGMS
56%
Loosely correlated
+1.13%
DYN - IGMS
51%
Loosely correlated
-0.35%
CRNX - IGMS
49%
Loosely correlated
-1.24%
MDGL - IGMS
42%
Loosely correlated
-0.55%
ATXS - IGMS
41%
Loosely correlated
+2.14%
More